Rufinamide-15N,d2 is the deuterium and 15N labeled version of Rufinamide, an orally active antiepileptic compound that functions by inhibiting Na+ current activation, inhibiting neuronal hyperexcitability, and providing anticonvulsant effects. It is utilized in the study of Lennox-Gastaut syndrome. This compound is intended for research use only and is not sold to patients. Stable heavy isotopes have been incorporated into drug molecules as tracers for quantitation during drug development. Deuteration can influence pharmacokinetic and metabolic profiles.
- Can be used as a tracer
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS